Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Inflammatory Breast Cancer: a Prospective Trial

NCT07080944 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07080944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07080944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Inflammatory Breast Cancer: a Prospective Trial
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
December 12, 2025
Completion date
August 31, 2030
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast carcinoma, neoadjuvant chemotherapy, sentinel lymph node biopsy (slnb)